Masoud H Manjili

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 22

Top Venues

Scandinavian journal of immunology

Journal of immunology (Baltimore, Md. : 1950)

Cancers

bioRxiv : the preprint server for biology

Virginia Commonwealth University

University of Sydney (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Virginia Commonwealth University Sep 01 2004

United States

Professor :: Microbiology & Immunology

Education History

University of Sydney Jun 01 1993 - Dec 16 1996

Australia

PHD :: Immunology

Publications

Nicholas Koelsch, Faridoddin Mirshahi, Hussein F Aqbi, Mulugeta Saneshaw, Michael O Idowu, Amy L Olex, Arun J Sanyal, Masoud H Manjili
Effective anti-tumor immune response against HCC is orchestrated by immune cell partnership network that functions through hepatic homeostatic pathways, not direct cytotoxicity. bioRxiv : the preprint server for biology (2024)
Masoud H Manjili, Saeed H Manjili
The quantum model of T-cell activation: Revisiting immune response theories. Scandinavian journal of immunology (2024)
Nicholas Koelsch, Faridoddin Mirshahi, Hussein F Aqbi, Mulugeta Saneshaw, Michael O Idowu, Amy L Olex, Arun J Sanyal, Masoud H Manjili
Effective anti-tumor immune response against HCC is orchestrated by immune cell partnership network that functions through hepatic homeostatic pathways, not direct cytotoxicity. bioRxiv : the preprint server for biology (2024)
Masoud H Manjili, Saeed H Manjili
The quantum model of T-cell activation: Revisiting immune response theories. Scandinavian journal of immunology 100 (2) (2024)
Masoud H Manjili, Saeed H Manjili
The quantum model of T-cell activation: Revisiting immune response theories. Scandinavian journal of immunology 100 (2) (2024)
Masoud H Manjili
The adaptation model of immunity: A new insight into aetiology and treatment of multiple sclerosis. Scandinavian journal of immunology 97 (4) (2023)
Masoud H Manjili
The Adaptation Model of Immunity: Signal IV Matters Most in Determining the Functional Outcomes of Immune Responses. Journal of immunology (Baltimore, Md. : 1950) 210 (5) (2023)
Masoud H Manjili
The Adaptation Model of Immunity: Signal IV Matters Most in Determining the Functional Outcomes of Immune Responses. Journal of immunology (Baltimore, Md. : 1950) 210 (5) (2023)
Nicholas Koelsch, Masoud H Manjili
From Reductionistic Approach to Systems Immunology Approach for the Understanding of Tumor Microenvironment. International journal of molecular sciences 24 (15) (2023)
Masoud H Manjili
The Adaptation Model of Immunity: Signal IV Matters Most in Determining the Functional Outcomes of Immune Responses. Journal of immunology (Baltimore, Md. : 1950) 210 (5) (2023)
Masoud H Manjili
The adaptation model of immunity: a new insight into etiology and treatment of multiple sclerosis. Scandinavian journal of immunology (2023)
Masoud H Manjili
The adaptation model of immunity: A new insight into aetiology and treatment of multiple sclerosis. Scandinavian journal of immunology 97 (4) (2023)
Masoud H Manjili
The Adaptation Model of Immunity: Signal IV Matters Most in Determining the Functional Outcomes of Immune Responses. Journal of immunology (Baltimore, Md. : 1950) 210 (5) (2023)
Masoud H Manjili
The adaptation model of immunity: A new insight into aetiology and treatment of multiple sclerosis. Scandinavian journal of immunology (2023)
Masoud H Manjili
The adaptation model of immunity: A new insight into aetiology and treatment of multiple sclerosis. Scandinavian journal of immunology 97 (4) (2023)
Masoud H Manjili
The adaptation model of immunity: Is the goal of central tolerance to eliminate defective T cells or self-reactive T cells? Scandinavian journal of immunology 96 (4) (2022)
Madison Isbell, Faridoddin Mirshahi, Hussein F Aqbi, Chunqing Guo, Mulugeta Saneshaw, Nicholas Koelsch, Michael O Idowu, Dana Austin, Cohava Gelber, Xiang-Yang Wang, Arun J Sanyal, Masoud H Manjili
Restoration of CD4 + T Cells during NAFLD without Modulation of the Hepatic Immunological Pattern Is Not Sufficient to Prevent HCC. Cancers 14 (22) (2022)
Rose H Manjili, Melika Zarei, Mehran Habibi, Masoud H Manjili
COVID-19 as an Acute Inflammatory Disease. Journal of immunology (Baltimore, Md. : 1950) 205 (1) (2020)
Hussein F Aqbi, Cara Coleman, Melika Zarei, Saeed H Manjili, Laura Graham, Jennifer Koblinski, Chunquing Guo, Yibin Xie, Georgi Guruli, Harry D Bear, Michael O Idowu, Mehran Habibi, Xiang-Yang Wang, Masoud H Manjili
Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsets. Breast cancer research : BCR 22 (1) (2020)
Rana Jahanban-Esfahlan, Khaled Seidi, Masoud H Manjili, Ali Jahanban-Esfahlan, Tahereh Javaheri, Peyman Zare
Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer. Cancers 11 (8) (2019)
Faridoddin Mirshahi, Hussein F Aqbi, Kellen Cresswell, Mulugeta Saneshaw, Cara Coleman, Taylor Jacobs, Michael O Idowu, Mikhail Dozmorov, Arun J Sanyal, Masoud H Manjili
Longitudinal studies can identify distinct inflammatory cytokines associated with the inhibition or progression of liver cancer. Liver international : official journal of the International Association for the Study of the Liver 40 (2) (2019)
Peng Zou, Longhua Liu, Louise D Zheng, Kyle K Payne, Masoud H Manjili, Michael O Idowu, Jinfeng Zhang, Eva M Schmelz, Zhiyong Cheng
Coordinated Upregulation of Mitochondrial Biogenesis and Autophagy in Breast Cancer Cells: The Role of Dynamin Related Protein-1 and Implication for Breast Cancer Treatment. Oxidative medicine and cellular longevity 2016 (2016)

Masoud H Manjili.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masoud H Manjili